Sleep Initiation and Maintenance Disorders: Clinical Trials

3 trials for Sleep Initiation and Maintenance Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 3

Follow Sleep Initiation and Maintenance Disorders: new trials by email Literature Review of Sleep Initiation and Maintenance Disorders trials Research Report on Sleep Initiation and Maintenance Disorders

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females
Zolpidem, ECG - Prostatic Neoplasms
Phase 1TerminatedNational Cancer Institute (NCI)122019-01-222026-06-26
Sleep Effectiveness and Insulin and Glucose Homeostasis
eszopiclone - Diabetes, Prediabetic
Phase 1TerminatedBeth Israel Deaconess Medical Center202012-10-012019-12-19
A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic Impairment
LY2624803 - Insomnia
Phase 1TerminatedEli Lilly and Company2010-11-012011-06-03

Narrower conditions

Diabetes Mellitus (1)  ·  Glucose Intolerance (1)  ·  Prediabetic State (1)  ·  Prostatic Neoplasms (1)

Broader conditions

Dyssomnias (3)  ·  Mental Disorders (3)  ·  Nervous System Diseases (3)  ·  Sleep Disorders, Intrinsic (3)  ·  Sleep Wake Disorders (3)  ·  Endocrine System Diseases (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperglycemia (1)  ·  Male Urogenital Diseases (1)  ·  Metabolic Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)

Interventions

Electrocardiography (1)  ·  Eszopiclone (1)  ·  Zolpidem (1)

Sponsors

Beth Israel Deaconess Medical Center (1)  ·  Eli Lilly and Company (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)  ·  Germany (1)  ·  Hungary (1)  ·  Russia (1)

Top investigators

Melanie Pogach, MD (1)  ·  William D Figg, Pharm.D. (1)